Source:http://linkedlifedata.com/resource/pubmed/id/16339486
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-6
|
pubmed:abstractText |
Raised levels of soluble P-selectin (sP-selectin) have been reported in the plasma of patients with vascular diseases; however, the functional importance of this ligand remains unclear. In this study we have examined a potential role for plasma sP-selectin in regulating neutrophil adhesion in patients with peripheral arterial occlusive disease (PAOD). Patients with PAOD had significantly higher levels of sP-selectin (mean+/-SD: 73.3+/-13.0 versus 16.7+/-6.4 ng/mL) and enhanced whole blood leukocyte adhesion to platelets under shear. To examine whether the raised sP-selectin levels can directly influence leukocyte adhesion, isolated neutrophils were incubated with plasma from PAOD patients before and after immunodepletion of sP-selectin. Neutrophil adhesion to fibrinogen increased 2-fold following incubation with PAOD plasma, which was abrogated on sP-selectin immunodepletion. We subsequently demonstrated that recombinant sP-selectin dose-dependently (75 to 250 ng/mL) increased leukocyte adhesion to fibrinogen and platelet monolayers. This increase was PSGL-1 and Src kinase-dependent and correlated with an increase in sP-selectin-mediated Mac-1 activation. sP-selectin-stimulated neutrophil adhesion to platelet monolayers was inversely correlated with shear, such that at low shear (50 s(-1)) a 92.7%+/-15.7 increase in adhesion was observed decreasing to 38.5%+/-11.9 at 150 s(-1) and 10.1%+/-7.4 at 300 s(-1). These studies suggest a potentially important role for sP-selectin in modulating neutrophil adhesion in patients with PAOD, particularly at sites of low shear, where it raises the possibility that raised plasma sP-selectin levels may enhance leukocyte recruitment to vascular injury and promote disease progression.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1524-4571
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
6
|
pubmed:volume |
98
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
149-56
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16339486-Aged,
pubmed-meshheading:16339486-Arterial Occlusive Diseases,
pubmed-meshheading:16339486-Cell Adhesion,
pubmed-meshheading:16339486-Female,
pubmed-meshheading:16339486-Fibrinogen,
pubmed-meshheading:16339486-Humans,
pubmed-meshheading:16339486-Leukocytes,
pubmed-meshheading:16339486-Male,
pubmed-meshheading:16339486-Middle Aged,
pubmed-meshheading:16339486-Neutrophils,
pubmed-meshheading:16339486-P-Selectin,
pubmed-meshheading:16339486-Peripheral Vascular Diseases
|
pubmed:year |
2006
|
pubmed:articleTitle |
Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion.
|
pubmed:affiliation |
Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute, Melbourne, Australia. Kevin.Woollard@baker.edu.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|